Screener
Lifecore Biomedical, Inc. LFCR Total Revenue
Total Revenue at other companies
Segments
Other financials
Where this comes from
Reported directly by Lifecore Biomedical, Inc. in its filing.
Tagged under the XBRL concept us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax.
The source filing: Lifecore Biomedical, Inc.’s 10-Q, filed August 5, 2026.
- Filed
- Aug 5, 2026, 7:20 AM EDT
- Fiscal quarter
- Q1 FY2027
- Calendar quarter
- Q3 2026
- Accession
- 0001005286-26-000033
| (in thousands, except share and per share amounts) | Three months ended / June 30,2026 | Three months ended / May 25,2025 | Six months ended / June 30,2026 | Six months ended / May 25,2025 |
|---|---|---|---|---|
| Revenues | $11,480 | $19,768 | $25,716 | $36,001 |
| Revenues, related party | 22,687 | 16,676 | 31,644 | 35,597 |
| Total revenues | 34,167 | 36,444 | 57,360 | 71,598 |
| Cost of sales | 22,092 | 22,462 | 40,823 | 47,771 |
| Gross profit | 12,075 | 13,982 | 16,537 | 23,827 |
| Research and development expenses | 1,537 | 2,103 | 2,754 | 4,148 |
| Selling, general, and administrative expenses | 7,971 | 8,980 | 15,888 | 19,073 |
| Restructuring recovery | — | (2,519) | — | (2,634) |
Item 1. Financial
FAQ
- What is Lifecore Biomedical, Inc.'s total revenue?
- Lifecore Biomedical, Inc. (LFCR) reported total revenue of $34.17M in Q2 2026.
- What is the long-term trend for Lifecore Biomedical, Inc.'s total revenue?
- Over 3 years (2022 to 2025), Lifecore Biomedical, Inc.'s total revenue has grown at a 5.0% compound annual growth rate (CAGR), from $111.27M to $128.87M.
- What does total revenue mean?
- The aggregate of all revenue from the company's operations — the top line from which all profitability metrics are derived.
Ask your AI about Lifecore Biomedical, Inc.'s total revenue.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude